These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2415478

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cellular quantitation of in vivo effects of 1-beta-D-arabinofuranosylcytosine on leukemia L1210.
    Edelstein M, Valeriote F, Vietti T.
    J Natl Cancer Inst; 1977 Apr; 58(4):941-7. PubMed ID: 845997
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
    Vietti TJ, Valeriote FA, Kalish R, Coulter D.
    Cancer Treat Rep; 1978 Sep; 62(9):1313-20. PubMed ID: 688275
    [Abstract] [Full Text] [Related]

  • 9. Heat sensitivities of murine normal and leukaemic haemopoietic stem cells: thermal inactivation energy and dependence on nutritional milieu.
    Symonds RP, Wheldon TE, Clarke BM.
    Br J Radiol; 1984 May; 57(677):421-2. PubMed ID: 6722438
    [No Abstract] [Full Text] [Related]

  • 10. Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice.
    Presant CA, Coulter D, Valeriote F, Vietti TJ.
    J Natl Cancer Inst; 1981 Jun; 66(6):1151-4. PubMed ID: 6165854
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the response to hyperthermia of murine haemopoietic stem cells (CFU-S) and L1210 leukaemia cells: enhanced killing of leukaemic cells in presence of normal marrow cells.
    Symonds RP, Wheldon TE, Clarke B, Bailey G.
    Br J Cancer; 1981 Nov; 44(5):682-91. PubMed ID: 7317271
    [Abstract] [Full Text] [Related]

  • 12. Experimental study on antitumor activity and pharmacokinetics of cytosine arabinoside, cyclocytidine and BH-AC.
    Takenaka T, Kimura K.
    Nihon Ketsueki Gakkai Zasshi; 1984 Jul; 47(4):938-49. PubMed ID: 6209907
    [No Abstract] [Full Text] [Related]

  • 13. Cytotoxicity of cytosine arabinoside on mouse progenitor stem cells.
    Sher A, Muller-Berat CN.
    Exp Pathol; 1982 Jul; 22(4):211-5. PubMed ID: 7160449
    [Abstract] [Full Text] [Related]

  • 14. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G, Valeriote F.
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
    Presant CA, Vietti T, Valeriote F.
    Cancer Res; 1975 Aug; 35(8):1926-30. PubMed ID: 50128
    [Abstract] [Full Text] [Related]

  • 17. Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus.
    Nakamura K, Eizuru Y, Kumura K, Minamishima Y.
    J Med Virol; 1990 Jun; 31(2):141-7. PubMed ID: 1696958
    [Abstract] [Full Text] [Related]

  • 18. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS, Ramonas LM.
    J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
    [Abstract] [Full Text] [Related]

  • 19. Comparison of cytotoxicity of single dose and infusion of alkylating agents.
    Valeriote F, Vietti T.
    Cancer Drug Deliv; 1985 May; 2(1):11-8. PubMed ID: 4052923
    [Abstract] [Full Text] [Related]

  • 20. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
    Colly LP, Peters WG, Willemze R.
    Cancer Res; 1986 Aug; 46(8):3825-7. PubMed ID: 3460691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.